An evaluation of 20 year survival in patients with diabetes mellitus and acute myocardial infarction

详细信息    查看全文

• 作者：Peysh A. Patel^a ; Richard M. Cubbon^a ; Robert J. Sapsford^b ; Richard G. Gillott^b ; Peter J. Grant^a ; Klaus K. Witte^a ; Mark T. Kearney^a ; Alistair S. Hall^b ; ^{A.S.Hall@leeds.ac.uk" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Diabetes ; Acute myocardial infarction ; Mortality ; Life expectancy
• 刊名：International Journal of Cardiology
• 出版年：2016
• 出版时间：15 January 2016
• 年：2016
• 卷：203
• 期：Complete
• 页码：141-144
• 全文大小：356 K

文摘

Diabetes mellitus (DM) is an established adverse prognostic factor in patients sustaining myocardial infarction (MI). However, its impact on long-term survival remains less clear. The aim of this observational study was to quantify lifetime mortality and years of life lost after MI in patients with and without DM.

Methods

In 1995, 2153 individuals with MI were recruited from 20 adjacent hospitals within Yorkshire, UK. Median survival, all-cause mortality at 20 years and lost years of life when compared to actuarial predictions were compared in patients with and without DM. Landmark analyses were conducted to define the ongoing impact of DM beyond specified time points.

Results

13% (279/2153) had known DM. They experienced higher mortality at 30 days (33.1% vs 24.6%; p < 0.0001) and at 20 years (84.9% vs 75.7%; p < 0.0001). Overall, there was a 48% increased risk of death (p < 0.0001), which persisted after adjustment for potential confounders. There was no interaction between DM and prior MI in predicting mortality (p = 0.67). Median survival decreased by 3.3 years (p < 0.0001). The adverse impact of DM persisted in sequential landmark analyses at 1, 5 and 10 years. Presence of DM conferred 2 extra years of life lost when compared with actuarial predictions (8 vs 6 years; p < 0.0001).

Conclusions

DM remains an independent adverse prognostic factor in the long-term after MI. Persistently diverging survival curves support enduring efforts to reduce mortality late after MI.